Affle 3I Secures Patent in India for AI Agent Monitoring and Integration System
Affle 3I Ltd has successfully secured a patent in India related to its technology that monitors and integrates intelligent conversational agents, further strengthening its intellectual property portfolio. This grant builds upon previous patents issued to the company in the US.The granted patent covers "System for Monitoring and Integration of One or More Intelligent Conversational Agents." This system functions as a mediation and monitoring layer designed to evaluate and unify multiple intelligent conversational agents or agentic platforms into a single, trust-score driven ecosystem.
By continuously assessing these agents based on behavioral intelligence, past performance, and privacy controlled sandbox evaluation, the technology ensures that only verified and high performing agents interact with consumers across Agentic/Autonomous Intelligent Connected Devices (AICDs).
This intellectual property extension enhances Affle's data distillation and fraud intelligence capabilities within the agentic AI layer. It reinforces the efficiency and future readiness of the company’s AI powered Consumer Platform Stack, ensuring trusted intelligent agents engage with consumers through AICDs. The patented technology further improves conversion driven marketing for advertisers.
As of the date of the patent grant, Affle's intellectual property portfolio consists of 18 unique patent grants out of a total of 39 filed patents. The company holds approximately 300 enforceable patent claims.
Key details regarding Affle’s Intellectual Property (IP) portfolio:
| Metric | Detail |
|---|---|
| Total Filed Patents | 39 |
| Unique Patent Grants | 18 |
| Enforceable Patent Claims | Approximately 300 |
AFFLE Stock Price Movement
Shares of Affle 3i Limited closed lower today, settling at ₹1436.20 after shedding 1.99% in trading. The stock experienced significant movement throughout the session, hitting a low of ₹1425.20 with a volume of 140,973 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.